Cervical Cancer clinical trials in North Dakota

11 actively recruiting cervical cancer trials at 5 sites across North Dakota.

Data from ClinicalTrials.gov · last refreshed 2026-07-07

Phase 3 Recruiting NIH

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) a…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06589804

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2, Phase 3 Recruiting Academic/Other

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy s…

Sponsor: NRG Oncology

NCT ID: NCT04333537

Sites in North Dakota:

Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Network

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. Radiation therapy uses high energy x-ra…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT02734537

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Sanford South University Medical Center — Fargo, North Dakota
Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT05136196

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota
Essentia Health - Jamestown Clinic — Jamestown, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma …

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT04671667

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

This phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer that has come back (recurrent), that has spread from where …

Sponsor: NRG Oncology

NCT ID: NCT05408845

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06064097

Sites in North Dakota:

Sanford Broadway Medical Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

The Minimalist Trial-2

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. Oropharynx SCC (OPSCC) is a common sub-type of HNSCC. Each year, 16,000 new cases of OPSCC are diagnosed in the USA. Most cases of OPSCC (\>90%) are caused by t…

Sponsor: Washington University School of Medicine

NCT ID: NCT06702033

Sites in North Dakota:

Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (adv…

Sponsor: Mayo Clinic

NCT ID: NCT05969860

Sites in North Dakota:

Altru Cancer Center — Grand Forks, North Dakota

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Sanford South University Medical Center — Fargo, North Dakota
Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
Sanford Medical Center Fargo — Fargo, North Dakota

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in North Dakota:

Massive Bio SYNERGY-AI site — Fargo, North Dakota

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-07-07